Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 10, 2026

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies

Published on: July 28, 2020

Multidisciplinary management of soft tissue sarcomas.

Ángel Montero Luis1, Damián Pérez Aguilar, José Antonio López Martín

  • 1FEA de Oncología Radioterápica, Hospital Universitario Ramón y Cajal, Madrid, Spain. angel.monteroluis@gmail.com

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
|August 17, 2010
PubMed
Summary

Musculoskeletal sarcomas, rare cancers from connective tissue, require integrated treatment. Optimal management focuses on survival, function, and minimizing morbidity through surgery, radiotherapy, and chemotherapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of high-risk prostate cancer in Spain: results from a national patterns of care survey.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2025
Same author

ESTRO recommendations on preoperative radiation therapy in breast cancer: current and future perspectives - Endorsed by ASTRO.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2025
Same author

Complete Remission With Fourth-Line Immunotherapy After Chemotherapy Failure in a Lung Cancer Patient With Severe Autoimmune Disease: An Unexpected Turn in Oncologic Management.

Cureus·2025
Same author

Reirradiation of gliomas with hypofractionated stereotactic radiotherapy: efficacy and tolerance analysis at a single center.

Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology·2025
Same author

Nivolumab and sunitinib in patients with advanced bone sarcomas: A multicenter, single-arm, phase 2 trial.

Cancer·2024
Same author

Prospective study on stereotactic body radiotherapy for small pancreatic neuroendocrine tumors: tolerance and effectiveness analysis.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2024

Area of Science:

  • Oncology
  • Orthopedics

Background:

  • Musculoskeletal sarcomas are diverse cancers originating from connective tissue, accounting for approximately 1% of adult cancers.
  • Incidence in Europe includes ~14,000 soft tissue sarcomas (STS) and ~4,800 bone sarcomas annually.
  • These tumors commonly affect lower extremities but can occur throughout the body.

Purpose of the Study:

  • To outline the challenges and optimal management strategies for musculoskeletal sarcomas.
  • To emphasize the importance of a multidisciplinary approach in treating these rare malignancies.

Main Methods:

  • Review of current treatment modalities for sarcomas.
  • Emphasis on the integration of surgery, radiotherapy, and chemotherapy.
  • Highlighting the necessity of specialized centers for patient care.

More Related Videos

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

Related Experiment Videos

Last Updated: Jun 10, 2026

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies

Published on: July 28, 2020

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

Main Results:

  • Treatment aims to improve survival, prevent local recurrence, maximize organ function, and minimize morbidity.
  • Multidisciplinary integration is crucial for effective treatment planning from diagnosis.
  • Referral to specialized centers is recommended for better outcomes.

Conclusions:

  • Effective management of musculoskeletal sarcomas necessitates a comprehensive, multidisciplinary strategy.
  • Optimizing patient outcomes requires a coordinated approach involving various treatment modalities.
  • Specialized care centers play a vital role in achieving maximal control and potential cure for STS.